iSentio

With the expansion and new hires, the company is making good on an earlier promise to use a $1.5 million financing round to increase its customer base in the US and European clinical markets.

Norway's iSentio is looking to expand the customer base for its web-based bacterial identification software and add additional support for existing subscribers in the US and Europe.

Paired Ends

Premium

Siri Fürst, Greg Critchfield

The company will use the funds to expand commercialization of its RipSeq software.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.